Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
DEN Open ; 3(1): e163, 2023 Apr.
Article in English | MEDLINE | ID: mdl-36176350

ABSTRACT

Objectives: Endoscopic submucosal resection with band ligation (ESMR-L) and endoscopic submucosal dissection (ESD) are both standard endoscopic resection methods for rectal neuroendocrine tumors (NETs) <10 mm in size. However, there is no definitive consensus on which is better. Here, we compared the efficacy of ESMR-L and ESD for small rectal NETs. Methods: This was a multicenter retrospective cohort study including 205 patients with rectal NETs who underwent ESMR-L or ESD. Treatment outcomes were compared by univariate analysis, multivariate analysis, and inverse probability treatment weighting (IPTW) using propensity scores. Subgroup analysis evaluated the impact of the endoscopist's experience on the technical outcome. Results: Eighty-nine patients were treated by ESMR-L and 116 by ESD. The R0 resection rate was not significantly different between the two (90% vs. 92%, p = 0.73). The procedure time of ESMR-L was significantly shorter than for ESD (17 min vs. 52 min, p < 0.01) and the hospitalization period was also significantly shorter (3 days vs. 5 days, p < 0.01). These results were confirmed by multivariate analysis and also after IPTW adjustment. The procedure time of ESD was significantly prolonged by a less-experienced endoscopist (49 min vs. 70 min, p = 0.02), but that of ESMR-L was not affected (17 min vs. 17 min, p = 0.27). Conclusions: For small rectal NETs, both ESMR-L and ESD showed similar high complete resection rates. However, considering the shorter procedure time and shorter hospitalization period, ESMR-L is the more efficient treatment method, especially for less-experienced endoscopists.

2.
Surg Today ; 47(4): 525-528, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27416774

ABSTRACT

The double stapling technique (DST) is an intestinal reconstruction technique that has been widely adopted in anterior resection (AR) for rectal cancer. However, anastomotic leakage (AL) after the operation remains a major concern for colorectal surgeons. The sharp-angled corner of the remnant rectum that is often created by the ordinary DST can be a risk factor for AL. We have developed a new method of performing intentional oblique transection DST (IOT-DST). Using this technique, the anal side of the rectum is intentionally obliquely transected with linear staplers, and the area of the sharp-angled edge is totally punched out with a circular stapler. Between September 2015 and March 2016, we used the IOT-DST technique in the treatment of 15 consecutive rectal cancer patients and experienced no anastomosis-related complications, including leakage and stenosis. IOT-DST is easy to use and less stressful to perform than other techniques. IOT-DST has the potential to become the standard technique for AR in rectal cancer surgery.


Subject(s)
Digestive System Surgical Procedures/methods , Plastic Surgery Procedures/methods , Rectal Neoplasms/surgery , Surgical Stapling/methods , Aged , Aged, 80 and over , Anastomotic Leak/prevention & control , Female , Humans , Male , Postoperative Complications/prevention & control , Treatment Outcome
3.
Nihon Shokakibyo Gakkai Zasshi ; 111(2): 334-9, 2014 02.
Article in Japanese | MEDLINE | ID: mdl-24500324

ABSTRACT

A 56-year-old woman was admitted to our hospital with fever and systemic malaise. Abdominal computed tomography revealed an enhanced tumor of the pancreatic head, measuring 9cm in maximal diameter and containing a low-density area. Subtotal stomach-preserving pancreatoduodenectomy was performed. Hemorrhage and necrosis were evident within the tumor, and osteoclastic polynuclear giant cells were also identified. A diagnosis of giant cell anaplastic ductal carcinoma of the pancreas was made. The patient has been free from recurrence for 6 months since surgery.


Subject(s)
Carcinoma, Giant Cell/surgery , Carcinoma, Pancreatic Ductal/surgery , Pancreatic Neoplasms/surgery , Carcinoma, Giant Cell/diagnosis , Carcinoma, Giant Cell/pathology , Carcinoma, Pancreatic Ductal/diagnosis , Carcinoma, Pancreatic Ductal/pathology , Female , Humans , Middle Aged , Organ Sparing Treatments , Pancreatic Neoplasms/diagnosis , Pancreatic Neoplasms/pathology , Pancreaticoduodenectomy/methods , Time Factors , Treatment Outcome
4.
Intern Med ; 41(2): 151-5, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11868605

ABSTRACT

Here, we report a case of systemic lupus erythematosus (SLE) complicated by cytomegalovirus (CMV)-induced hemophagocytic syndrome (HPS) and colitis. A 44-year-old woman with SLE was treated with corticosteroid and cyclophosphamide for lupus nephritis. Although her lupus nephritis improved, fever, progressive pancytopenia and intestinal bleeding were observed. A bone marrow aspiration showed an increase in mature histiocytes with hemophagocytosis. In addition, a colonoscopy showed hemorrhagic colitis with ulcer and the biopsy specimen from the colon revealed typical CMV cells with CMV inclusions confirmed by immunohistochemistry. Furthermore, a large number of CMV antigen-positive leukocytes was detected, suggesting an active CMV infection. CMV infection is serious in compromised hosts. Therefore clinicians should be aware of the clinical settings in which this infection can arise and the target organs potentially affected in order to initiate the appropriate intervention.


Subject(s)
Autoimmune Diseases/complications , Colitis/complications , Cytomegalovirus Infections/complications , Histiocytosis, Non-Langerhans-Cell/complications , Lupus Erythematosus, Systemic/complications , Adult , Agammaglobulinemia/etiology , Autoimmune Diseases/drug therapy , Colitis/virology , Cyclophosphamide/adverse effects , Cyclophosphamide/therapeutic use , Cytomegalovirus/isolation & purification , Fatal Outcome , Female , Gastrointestinal Hemorrhage/etiology , Humans , Immunocompromised Host , Immunosuppressive Agents/adverse effects , Intestinal Perforation/etiology , Leukocytes/virology , Lupus Erythematosus, Systemic/drug therapy , Lupus Nephritis/complications , Multiple Organ Failure/etiology , Prednisolone/adverse effects , Prednisolone/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...